drug

BNT166A

1 story · latest Sep 15, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by BioNTech SE

Timeline

BioNTech posts results for mpox vaccine BNT166a Phase I/II trial NCT05988203

Sep 15Trial updateBioNTech SE BNT166A

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.